Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fallowfield

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2016
Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefitsL J Fallowfield, S L Catt, S F May, et al.
Breast Cancer Research and Treatment|September 16, 2005
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancerAnne Fleissig, Lesley J Fallowfield, Carolyn I Langridge, et al.
British Journal of Cancer|February 1, 1993
A daily diary for quality of life measurement in advanced breast cancer trialsS C Fraser, A J Ramirez, S R Ebbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancerLesley J Fallowfield, Judith M Bliss, Lucy S Porter, et al.
Journal of the National Cancer Institute|August 7, 2009
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapyFatima Cardoso, Philippe L Bedard, Eric P Winer, et al.
Breast Cancer Research and Treatment|September 8, 2010
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerabilityJ Michael Dixon, Lorna Renshaw, Carolyn Langridge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2012
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidS Vadhan-Raj, R von Moos, L J Fallowfield, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2013
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acidRoger von Moos, Jean-Jacques Body, Blair Egerdie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 7, 2004
Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancerMatthew R Sydes, Richard J Stephens, A Rollo Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline UpdateHarold J Burstein, Mark R Somerfield, Debra L Barton, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2016
Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefitsL J Fallowfield, S L Catt, S F May, et al.
Breast Cancer Research and Treatment|September 16, 2005
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancerAnne Fleissig, Lesley J Fallowfield, Carolyn I Langridge, et al.
British Journal of Cancer|February 1, 1993
A daily diary for quality of life measurement in advanced breast cancer trialsS C Fraser, A J Ramirez, S R Ebbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancerLesley J Fallowfield, Judith M Bliss, Lucy S Porter, et al.
Journal of the National Cancer Institute|August 7, 2009
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapyFatima Cardoso, Philippe L Bedard, Eric P Winer, et al.
Breast Cancer Research and Treatment|September 8, 2010
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerabilityJ Michael Dixon, Lorna Renshaw, Carolyn Langridge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2012
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidS Vadhan-Raj, R von Moos, L J Fallowfield, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2013
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acidRoger von Moos, Jean-Jacques Body, Blair Egerdie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 7, 2004
Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancerMatthew R Sydes, Richard J Stephens, A Rollo Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline UpdateHarold J Burstein, Mark R Somerfield, Debra L Barton, et al.
Pageof 12